Mirae Asset Global Etfs Holdings Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 80,388 shares of XERS stock, worth $288,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,388
Previous 76,941
4.48%
Holding current value
$288,592
Previous $219,000
24.2%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
162Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$37.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$28.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$12 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$12 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$10.3 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $488M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...